1. Current urology reports—what makes us different?

   • Steven A. Kaplan

   Editor’s Commentary Pages: 1 - 2

2. Web alert

   News Pages: 3 - 4

3. Literature alert

   OriginalPaper Pages: 5 - 6

4. Neoadjuvant hormone therapy before radical prostatectomy does not improve disease-specific survival

   • Mitchell S. Steiner

   Clinical Trials Review Pages: 7 - 8

5. New insights and candidate genes and their implications for care of patients with hereditary prostate cancer

   • Hyung L. Kim
   • Gary D. Steinberg

   OriginalPaper Pages: 9 - 14

6. The role of prostate-specific antigen velocity in prostate cancer early detection

   • Steven R. Potter
   • H. Ballentine Carter

   OriginalPaper Pages: 15 - 19

7. Continence-preserving anatomic radical retropubic prostatectomy: The “no-touch” technique

   • Mitchell S. Steiner

   OriginalPaper Pages: 20 - 27

8. What does prostate-specific antigen recurrence mean?

   • Charles R. Pound
   • Alan W. Partin

   OriginalPaper Pages: 28 - 35

9. Laparoscopic radical prostatectomy

   • Arnon Krongrad

   OriginalPaper Pages: 36 - 40

10. Cryosurgery for prostate cancer: New technology and indications

    • Ronald M. Benoit
    • Jeffrey K. Cohen
    • Ralph J. Miller

    OriginalPaper Pages: 41 - 47

11. Recent advances in chemotherapy for advanced prostate cancer

    • Karin B. Olson
    • Kenneth J. Pienta

    OriginalPaper Pages: 48 - 56

12. Screening for prostate cancer in african americans

    • Judd W. Moul

    OriginalPaper Pages: 57 - 64

13. Prostatic intraepithelial neoplasia

    • David G. Bostwick

    OriginalPaper Pages: 65 - 70

14. Quality of life following prostate cancer treatments

    • David F. Penson

    OriginalPaper Pages: 71 - 77

15. The role of free prostate-specific antigen in prostate cancer detection

    • Misop Han
    • Steven R. Potter
    • Alan W. Partin

    OriginalPaper Pages: 78 - 82